Industry & Services >> CEO Interviews >> December 17, 2001
DAVID BECKER has been Executive Vice President and Chief Financial Officer at
MiddleBrook Pharmaceuticals, Inc., since September 2008. Prior to joining
MiddleBrook, he served as an independent consultant to various healthcare
companies from March 2007 to June 2008, providing them with Chief Financial
Officer and/or Chief Executive Officer services. In addition, Mr. Becker sat on
the Board of Directors for several of these healthcare companies. From 2000 to
2007, he served as the Chief Financial Officer and Treasurer of Adams
Respiratory Therapeutics, Inc., and served in various other capacities with
Adams over that period, including Chief Financial and Administrative Officer
from October 2006 to February 2007, and interim Chief Operating Officer from May
2003 to April 2004. Prior to joining Adams, Mr. Becker was a senior manager in
the merger and acquisitions practice of Ernst & Young LLP from November 1997 to
September 2000. From January 1996 to November 1997, Mr. Becker served as
Controller for the Salt Lake City-based startup company RxAmerica LLC, a
pharmacy benefit management and mail-service pharmacy operation. From 1991 to
1995, he served as a financial auditor with Ernst & Young LLP. Mr. Becker began
his professional career in 1990 as an audit and tax accountant for the Southern
California-based accounting firm of Glenn M. Gelman & Associates. He earned a
Bachelor's degree in Accounting in 1990 from the University of Southern
Mississippi and is a Certified Public Accountant and Certified Treasury
Professional. Profile
evolution of i2?
Mr. Becker: i2 was founded in 1988 by Ken Sharma and Sanjiv Sidhu, in a
small Dallas apartment, to create high
